Targeting Epidermal Growth Factor Receptor to Stimulate Elastic Matrix Regenerative Repair
Tissue Engineering Part A · 2023
DOI: 10.1089/ten.tea.2022.0170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, 2023. Verfasst von Simran Dayal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Leukocyte Elastase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Abdominal aortic aneurysms (AAAs) represent a multifactorial, proteolytic disorder involving disintegration of the matrix structure within the AAA wall. Intrinsic deficiency of adult vascular cells to regenerate and repair the wall elastic matrix, which contributes to vessel stretch and recoil, is a major clinical challenge to therapeutic reversal of AAA growth. In this study, we investigate the involvement of epidermal growth factor receptor-mitogen activated protein kinase (EGFR-MAPK) pathway in the activation of aneurysmal smooth muscle cells (SMCs) by neutrophil elastase, and how EGFR can be targeted for elastic matrix regeneration. We have demonstrated that neutrophil elastase activates EGFR and downregulates expression level of key elastin homeostasis genes (elastin, crosslinking enzyme-lysyl oxidase, and fibulin4) between a dose range of 1-10 μg/mL (p < 0.05). It also incites downstream proteolytic outcomes by upregulating p-extracellular signal-regulated kinase (ERK)1/2 (p < 0.0001) and matrix metalloprotease 2 (MMP2) at a protein level, which is significantly downregulated upon EGFR-specific inhibition by tyrosine kinase inhibitor AG1478 (p-ERK1/2 and MMP2 [p < 0.05]). Moreover, we have shown that EGFR inhibition suppresses collagen amounts in aneurysmal SMCs (p < 0.05) and promotes robust formation of elastic fibers by enhancing its deposition in the extracellular space. Hence, the EGFR-MAPK pathway in aneurysmal cells can be targeted to provide therapeutic effects toward stimulating vascular matrix regeneration. Impact statement Proteolytic disorders such as aortal expansions, called abdominal aortic aneurysms (AAAs), are characterized by naturally irreversible enzymatic breakdown and loss of elastic fibers, a problem that has not yet been surmounted by existing tissue engineering approaches. In this work, we show, for the first time, how epidermal growth factor receptor (EGFR) inhibition provides downstream benefits in elastic fiber assembly and deposition in aneurysmal smooth muscle cell cultures. This work can open future possibilities for development of EGFR-targeted drug-based therapies not only for vessel wall repair in AAAs but also other proteolytically compromised elastic tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA.
- Department of Cell Biology and Physiology, Washington University, St. Louis, Missouri, USA.
ORCID-Profile: Simran Dayal
Förderung
- NHLBI NIH HHS
Zitieren
APA
Dayal, S., Broekelmann, T., Mecham, R. P., & Ramamurthi, A. (2023). Targeting Epidermal Growth Factor Receptor to Stimulate Elastic Matrix Regenerative Repair. Tissue Engineering Part A. https://doi.org/10.1089/ten.tea.2022.0170
Vancouver
Dayal S, Broekelmann T, Mecham RP, Ramamurthi A. Targeting Epidermal Growth Factor Receptor to Stimulate Elastic Matrix Regenerative Repair. Tissue Engineering Part A. 2023. doi:10.1089/ten.tea.2022.0170
BibTeX
@article{Dayal2023,
author = {Dayal, Simran and Broekelmann, Thomas and Mecham, Robert P and Ramamurthi, Anand},
title = {Targeting Epidermal Growth Factor Receptor to Stimulate Elastic Matrix Regenerative Repair},
journal = {Tissue Engineering Part A},
year = {2023},
doi = {10.1089/ten.tea.2022.0170}
}
EUVIMED